Subscribe
shutterstock_2091347611_ralf_liebhold
Ralf Liebhold / Shutterstock.com
15 February 2022GenericsAlex Baldwin

Afrigen creates COVID vaccine using Moderna data

Afrigen Biologics has used the publicly available information relating to Moderna’s COVID-19 vaccine to manufacture its own version of the treatment, which could see testing by the end of this year.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Moderna aims to offset COVID vaccine lawsuit to US govt
10 May 2022   Moderna has rejected claims that its COVID-19 vaccine violates the patent rights of two biopharma companies, arguing that its contract with the US federal government has conferred immunity.
Big Pharma
Moderna pledges to not enforce COVID-19 patents in 92 states
8 March 2022   Moderna has stated that it will “never” enforce its COVID-19 patents in 92 low and middle-income countries.
Americas
Moderna in dispute with US govt over COVID-19 vaccine inventors
11 November 2021   Moderna is facing accusations from the US National Institute of Health that it failed to give due recognition to three scientists as inventors on its COVID-19 vaccine application.


Editor's picks

In-house with Bayer: ‘Focus on quality early and stay close to inventors’
Europe
In-house with Bayer: ‘Focus on quality early and stay close to inventors’
15 July 2025

Editor's picks

Europe
In-house with Bayer: ‘Focus on quality early and stay close to inventors’
15 July 2025
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025

More on this story

Americas
Moderna aims to offset COVID vaccine lawsuit to US govt
10 May 2022   Moderna has rejected claims that its COVID-19 vaccine violates the patent rights of two biopharma companies, arguing that its contract with the US federal government has conferred immunity.
Big Pharma
Moderna pledges to not enforce COVID-19 patents in 92 states
8 March 2022   Moderna has stated that it will “never” enforce its COVID-19 patents in 92 low and middle-income countries.
Americas
Moderna in dispute with US govt over COVID-19 vaccine inventors
11 November 2021   Moderna is facing accusations from the US National Institute of Health that it failed to give due recognition to three scientists as inventors on its COVID-19 vaccine application.

More on this story

Americas
Moderna aims to offset COVID vaccine lawsuit to US govt
10 May 2022   Moderna has rejected claims that its COVID-19 vaccine violates the patent rights of two biopharma companies, arguing that its contract with the US federal government has conferred immunity.
Big Pharma
Moderna pledges to not enforce COVID-19 patents in 92 states
8 March 2022   Moderna has stated that it will “never” enforce its COVID-19 patents in 92 low and middle-income countries.
Americas
Moderna in dispute with US govt over COVID-19 vaccine inventors
11 November 2021   Moderna is facing accusations from the US National Institute of Health that it failed to give due recognition to three scientists as inventors on its COVID-19 vaccine application.

More features

AbbVie blocks Humira antitrust suit
WATCH: Enabling success—mastering s112 in the new era of life sciences patents
AstraZeneca suffers defeat over $7bn diabetes patent
US firm Brownstein nabs five from Crowell ‘at pivotal moment’
American Regent secures rare PI win in Hatch-Waxman dispute
WATCH: Patents s101—how to overcome the current complexity of patent eligibility in the US
In-house with Bayer: ‘Focus on quality early and stay close to inventors’
J&J sues over schizophrenia drug generic following patent victory